Impact of Prior Tuberculosis Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for Multidrug- and Rifampicin-Resistant Tuberculosis is a research paper published in Clinical Infectious Diseases (2023). On theSindex it has a DataRank of 0.360. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Allergy and Infectious Diseases
Grant: R21AI122001
NIAID NIH HHS
Grant: P30 AI168386
NCATS NIH HHS
Grant: TL1 TR002382
FIC NIH HHS
Grant: D43TW007124
NCATS NIH HHS
Grant: KL2 TR002381
NCATS NIH HHS
Grant: UL1 TR002378
NIA NIH HHS
Grant: U54 AG062334
NIH HHS
National Institutes of Health
MeSH Terms
Keywords